Overall Survival Rates Differ Among Patients with Cancer of Different Races and Ethnicities
A recent study examined the differences in stage of leading cancer types at diagnosis, treatment and overall survival of patients according to different races and ethnicities. (Source: CancerNetwork)
Source: CancerNetwork - April 18, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news

Researchers Outline Recommendations for Testing Patients with Lung Cancer for COVID-19
Researchers outlined recommendations for testing patients with lung cancer for COVID-19, given their specific cumulative risk factors for COVID-19 complications. (Source: CancerNetwork)
Source: CancerNetwork - April 18, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

FDA Approves Pemigatinib for Advanced Cholangiocarcinoma
This is the first FDA approval for this patient population. (Source: CancerNetwork)
Source: CancerNetwork - April 18, 2020 Category: Cancer & Oncology Authors: Brielle Benyon Source Type: news

Quiz: Evolving Treatment Options in BRAF V600E Mutant Metastatic Colorectal Cancer
In our gastrointestinal cancer quiz, you ’ll get a chance to test your knowledge on the BRAF V600E mutation in patients with colorectal cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 17, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

NCCN Offers Strategies and Best Safety Practices During the COVID-19 Pandemic
The JNCCN outlined strategies and best safety practices during the COVID-19 pandemic for patients, caregivers, and healthcare workers. (Source: CancerNetwork)
Source: CancerNetwork - April 17, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Experts Address Difficulties in Lung Cancer Management During COVID-19 Pandemic
Researchers detailed the challenges presented for lung cancer therapy during the COVID-19 pandemic and how to potentially mitigate them. (Source: CancerNetwork)
Source: CancerNetwork - April 17, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

FDA Approves Tucatinib in Combination with Chemotherapy for HER2-Positive Breast Cancer
The FDA approved tucatinib in combination with chemotherapy for the treatment of adult patients with advanced forms of HER2-positive breast cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 17, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Targeted Intraoperative Radiotherapy vs External Beam Radiotherapy in Patients with Breast Cancer
This study examined delayed targeted intraoperative radiotherapy vs external beam radiotherapy to determine how it impacted patients with breast cancer, finding no statically significant decrease in mastectomy-free survival, distant-disease survival or overall survival. (Source: CancerNetwork)
Source: CancerNetwork - April 16, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news

Economic Evaluation of CAR T-Cell Therapies by Site Care for Large B-Cell Lymphomas
Researchers found that the potential availability of CAR T-cell therapies for large B-cell lymphomas with lower adverse event rates that are suitable for outpatient administration may reduce the total costs of care. (Source: CancerNetwork)
Source: CancerNetwork - April 16, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Judd W. Moul, MD, FACS, on Triaging Patients with Prostate Cancer
The prostate cancer expert discussed guidelines that he and his colleagues culminated for triaging patients with prostate cancer during the COVID-19 pandemic. (Source: CancerNetwork)
Source: CancerNetwork - April 16, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Medical Groups Release Recommendations for Breast Cancer Care During COVID-19 Pandemic
A group of expert medical societies developed joint recommendations for healthcare professionals and patients to guide the prioritization, treatment and triage of breast cancer during the COVID-19 pandemic. (Source: CancerNetwork)
Source: CancerNetwork - April 16, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news

ASCO Registry Launched to Learn More About COVID-19 in Patients with Cancer
The registry, titled the ASCO Survey on COVID-19 in Oncology Registry, will collect both baseline and follow-up data throughout the COVID-19 pandemic and into 2021. (Source: CancerNetwork)
Source: CancerNetwork - April 15, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

AstraZeneca Announces CALAVI Trial to Examine Acalabrutinib for Patients with COVID-19
AstraZeneca announced it will be conducting a global clinical trial, CALAVI, to examine the impact of adding acalabrutinib to best supportive care for patients who are severely ill with the COVID-19 infection. (Source: CancerNetwork)
Source: CancerNetwork - April 15, 2020 Category: Cancer & Oncology Authors: Matthew Fowler Source Type: news

FDA Approves Mitomycin Gel for Upper Tract Urothelial Cancer
The FDA approved mitomycin gel (Jelmyto), the first therapy to treat low-grade upper tract urothelial cancer. (Source: CancerNetwork)
Source: CancerNetwork - April 15, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news

Mammographic Breast Density, Microcalcifications, and Masses May be Inheritable
Given that these features are associated with breast cancer risk and could improve the detection of short-term risk of breast cancer, the authors suggested that further investigation of common loci is necessary. (Source: CancerNetwork)
Source: CancerNetwork - April 15, 2020 Category: Cancer & Oncology Authors: Hannah Slater Source Type: news